# Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non–Small-Cell Lung Cancer: Analysis and Literature Review

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/anaplastic-lymphoma-kinase-alk-kinase-domain-mutation-following-alk-inhibitor-s/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yen‐Ting Lin,Chong‐Jen Yu,James Chih‐Hsin Yang,Jin‐Yuan Shih |
| Citations | 35 |
| DOI | 10.1016/j.cllc.2016.03.005 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2319183095 |
| PMID | 27130468 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Yen‐Ting Lin](https://scholariq.org/researchers/yen-ting-lin/)

## Paper journal

- [Clinical Lung Cancer](https://scholariq.org/journals/clinical-lung-cancer/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.